Single Nucleotide Polymorphisms in Thyroid Hormone Transporter Genes MCT8, MCT10 and Deiodinase DIO2 Contribute to Inter-Individual Variance of Executive Functions and Personality Traits

Abstract

Thyroid hormones are modulators of cognitive functions, and changes in hormone levels affect intelligence, memory, attention and executive function. Single nucleotide polymorphisms (SNPs) of transporter proteins MCT8, MCT10 and deiodinase 2 (DIO2) influence thyroid metabolism and could therefore contribute to inter-individual variance of cognitive functions. This study investigates the influence of these SNPs using an extensive neuropsychological test battery. 656 healthy participants aged 18–39 years were genotyped for four SNPs: MCT8 (rs5937843 and rs6647476), MCT10 (rs14399) and DIO2 (rs225014) and underwent eleven different neuropsychological tests as well as four personality questionnaires. Test results were compared between homo- and heterozygous carriers and for the X-linked MCT8 additionally between men and women. Personality questionnaires revealed that Risk Seeking was reduced in homozygous T carriers and highest in homozygous C carriers of the DIO2 SNP and that both polymorphisms of MCT8 had an additive effect on Physical Aggression in men. Neuropsychological testing indicated that MCT10 affects nonverbal reasoning abilities, DIO2 influences working memory and verbal fluency and MCT8 influences attention, alertness and planning. This pilot study suggests an influence of polymorphisms in thyroid hormone transporter genes and deiodinase on cognitive domains and personality traits.

Key words

thyroid hormones - thyroid hormone transporter - MCT, deiodinase - single nucleotide polymorphism - cognitive function - personality traits

Publication History

Received: 20 April 2019
Received: 19 August 2019

Accepted: 18 November 2019

Article published online:
09 December 2019

• References

• 1 Bauer M, Goetz T, Glenn T. et al. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 2008; 20: 1101-1114
• 2 Samuels MH. Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes 2008; 15: 429-433
• 3 Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes 2014; 21: 377-383
• 4 Zhang W, Song L, Yin X. et al. Grey matter abnormalities in untreated hyperthyroidism: a voxel-based morphometry study using the DARTEL approach. Eur J Radiol 2014; 83: e43-e48
• 5 Göbel A, Heldmann M, Göttlich M. et al. Effect of Mild Thyrotoxicosis on Performance and Brain Activations in a Working Memory Task. Walter M, editor. PLOS ONE 2016; 11: e0161552
• 6 Brent GA. Mechanisms of thyroid hormone action. J Clin Invest 2012; 122: 3035-3043
• 7 Friesema ECH, Ganguly S, Abdalla A. et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003; 278: 40128-40135
• 8 Lafrenière RG, Carrel L, Willard HF. A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Hum Mol Genet 1994; 3: 1133-1139
• 9 Kim DK, Kanai Y, Matsuo H. et al. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 2002; 79: 95-103
• 10 Zhou Y, Samson M, Francon J. et al. Thyroid hormone concentrative uptake in rat erythrocytes. Involvement of the tryptophan transport system T in countertransport of tri-iodothyronine and aromatic amino acids. Biochem J 1992; 281 (Pt 1) 81-86
• 11 Bianco AC, Larsen PR. Cellular and structural biology of the deiodinases. Thyroid Off J Am Thyroid Assoc 2005; 15: 777-786
• 12 Gereben B, Zavacki AM, Ribich S. et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008; 29: 898-938
• 13 Davey JC, Becker KB, Schneider MJ. et al. Cloning of a cDNA for the type II iodothyronine deiodinase. J Biol Chem 1995; 270: 26786-26789
• 14 Salvatore D, Bartha T, Harney JW. et al. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinol 1996; 137: 3308-3315
• 15 Croteau W, Davey JC, Galton VA. et al. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 1996; 98: 405-417
• 16 Gereben B, Bartha T, Tu HM. et al. Cloning and expression of the chicken type 2 iodothyronine 5'—deiodinase. J Biol Chem 1999; 274: 13768-13776
• 17 Campos-Barros A, Hoell T, Musa M. et al. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J Clin Endocrinol Metab 1996; 81: 2179-2185
• 18 Riskind PN, Kolodny JM, Larsen PR. The regional hypothalamic distribution of type II 5’-monodeiodinase in euthyroid and hypothyroid rats. Brain Res 1987; 420: 194-198
• 19 Tu HM, Kim SW, Salvatore D. et al. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinol 1997; 138: 3359-3368
• 20 Guadano-Ferraz A, Obregón MJ, Germain DL. et al. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Nat Acad Sci USA 1997; 94: 10391-10396
• 21 Tu HM, Legradi G, Bartha T. et al. Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinol 1999; 140: 784-790
• 22 Müller J, Mayerl S, Visser TJ. et al. Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency. Endocrinology 2014; 155: 315-325
• 23 Bernal J. The significance of thyroid hormone transporters in the brain. Endocrinol 2005; 146: 1698-1700
• 24 Braun D, Wirth EK, Schweizer U. Thyroid hormone transporters in the brain. Rev Neurosci 2010; 21: 173-186
• 25 Friesema EC, Grueters PA, Biebermann H. et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004; 364: 1435-1437
• 26 Visser WE, Friesema EC, Jansen J. et al. Thyroid hormone transport in and out of cells. Trends Endocrinol Metab 2008; 19: 50-56
• 27 Dumitrescu AM, Liao XH, Best TB. et al. A Novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74: 168-175
• 28 Schwartz CE, May MM, Carpenter NJ. et al. AllanHerndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 2005; 77: 41-53 14
• 29 Heuer H. The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 2007; 21: 265-276
• 30 Ceballos A, Belinchon MM, Sanchez-Mendoza E. et al. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'-triiodo-L-thyronine. Endocrinol 2009; 150: 2491-2496
• 31 Roberts LM, Woodford K, Zhou M. et al. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinol 2008; 149: 6251-6261
• 32 Jansen J, Friesema ED, Milici C. et al. Thyroid hormone transporters in health and disease. Thyroid 2005; 15: 757-768
• 33 Braun D, Kinne A, Brauer AU. et al. Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells. Glia 2011; 59: 463-471
• 34 van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol 2010; 44: 1-11
• 35 Roef GL, Rietzschel ER, De Meyer T. et al. Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones. Clin Chim Acta Int J Clin Chem 2013; 425: 227-232
• 36 Lago-Lestón R, Iglesias M-J, San-José E. et al. Prevalence and functional analysis of the S107P polymorphism (rs6647476) of the monocarboxylate transporter 8 (SLC16A2) gene in the male population of north-west Spain (Galicia). Clin Endocrinol (Oxf) 2009; 70: 636-643
• 37 Castagna MG, Dentice M, Cantara S. et al. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients. J Clin Endocrinol Metab 2017; 102: 1623-1630
• 38 Ettinger U, Merten N, Kambeitz J. Meta-analysis of the association of the SLC6A3 3’-UTR VNTR with cognition. Neurosci Biobehav Rev 2016; 60: 72-81
• 39 Klaus K, Butler K, Curtis F. et al. The effect of ANKK1 Taq1A and DRD2 C957T polymorphisms on executive function: A systematic review and meta-analysis. Neurosci Biobehav Rev 2019; 100: 224-236
• 40 Lin C-H, Lin E, Lane H-Y. Genetic Biomarkers on Age-Related Cognitive Decline. Front Psychiatry 2017; 8: 247
• 41 Toh YL, Ng T, Tan M. et al. Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review. Brain Behav 2018; 8: e01009
• 42 Qiu X, Martin GB, Blache D. Gene polymorphisms associated with temperament. J Neurogenet 2017; 31: 1-16
• 43 Rana BK, Darst BF, Bloss C. et al. Candidate SNP associations of optimism and resilience in older adults: exploratory study of 935 community-dwelling adults. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry 2014; 22: 997-1006.e5
• 44 Reif A, Lesch K-P. Toward a molecular architecture of personality. Behav Brain Res 2003; 139: 1-20
• 45 Tielbeek JJ, Karlsson Linnér R, Beers K. et al. Meta-analysis of the serotonin transporter promoter variant (5-HTTLPR) in relation to adverse environment and antisocial behavior. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc. Psychiatr Genet 2016; 171: 748-760
• 46 Eysenck SB, Pearson PR, Easting G. et al. Age norms for impulsiveness, venturesomeness and empathy in adults. Personal Individ Differ 1985; 6: 613-619
• 47 Luengo MA, Carrillo-de-la-Peña MT, Otero JM. The components of impulsiveness: A comparison of the I.7 Impulsiveness Questionnaire and the Barratt Impulsiveness Scale. Personal Individ Differ 1991; 12: 657-667
• 48 Rodrίguez-Fornells A, Kurzbuch AR, Münte TF. Time Course of Error Detection and Correction in Humans: Neurophysiological Evidence. J Neurosci 2002; 22: 9990-9996
• 49 Torrubia R, Ávila C, Moltó J. et al. The Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ) as a measure of Gray’s anxiety and impulsivity dimensions. Personal Individ Differ 2001; 31: 837-862
• 50 Gray JA. Oxford psychology series. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. 1st ed. New York, NY, USA: Clarendon Press/Oxford University Press; 1982
• 51 Broadbent DE, Cooper PF, FitzGerald P. et al. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21: 1-16
• 52 Buss AH, Perry M. The Aggression Questionnaire. J Pers Soc Psychol 1992; 63: 452-459
• 53 Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957; 21: 343-349
• 54 Eriksen BA, Eriksen CW. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys. 1974; 1 16: 143-149
• 55 Band GPH, van der Molen MW, Logan GD. Horse-race model simulations of the stop-signal procedure. Acta Psychol (Amst) 2003; 112: 105-142
• 56 Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662
• 57 Jaeggi SM, Buschkuehl M, Perrig WJ. et al. The concurrent validity of the N-back task as a working memory measure. Mem Hove Engl 2010; 18: 394-412
• 58 Zimmermann P, Fimm B. A test battery for attentional performance. In: Applied Neuropsychology of Attention Theory, Diagnosis and Rehabilitation 1st ed. London, UK: Psychology Press; 2002: P110-151
• 59 Von Aster M, Neubauer A, Horn RWIE. Wechsler Intelligenztest fuer Erwachsene. Deutschsprachige Bearbeitung und Adaptation des WAIS-III von David Wechsler. Frankfurt am Main, Deutschland: Hartcourt Test Services; 2006
• 60 Caramelli P, Carthery-Goulart MT, Porto CS. et al. Category fluency as a screening test for Alzheimer disease in illiterate and literate patients. Alzheimer Dis Assoc Disord 2007; 21: 65-67
• 61 Reitan RM. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept Mot Skills 1958; 8: 271-276
• 62 Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex J Devoted Study Nerv Syst Behav 1976; 12: 313-324
• 63 Culbertson WC, Zillmer EA. The Tower of London(DX): a standardized approach to assessing executive functioning in children. Arch Clin Neuropsychol 1998; 13: 285-301
• 64 Luo M, Zhou XH, Zou T. et al. Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment. Genet Mol Res 2015; 14: 5407-5416
• 65 McAninch EA, Rajan KB, Evans DA. et al. A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans. J Clin Endocrinol Metab 2018; 103: 1818-1826
• 66 HJCM Wouters, van Loon HCM, van der Klauw MM. et al. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study. Thyroid Off J Am Thyroid Assoc 2017; 27: 147-155
• 67 Gałecka E, Talarowska M, Orzechowska A. et al. Polymorphisms in the type I deiodinase gene and frontal function in recurrent depressive disorder. Adv Med Sci 2016; 61: 198-202
• 68 Jo S, Fonseca TL, Bocco BMLC. et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J Clin Invest 2019; 129: 230-245
• 69 Jern P, Ventus D. Serotonergic polymorphisms in the control of ejaculation. Mol Cell Endocrinol 2018; 15: 60-65
• 70 Cooper DN. Functional intronic polymorphisms: Buried treasure awaiting discovery within our genes. Hum Genomics 2010; 4: 284-288